Dean L Schorno Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dean L Schorno.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dean L Schorno. Dean L Schorno is EVP &Chief Financial Officer in RIGEL PHARMACEUTICALS INC ($RIGL) and CFO in GENOMIC HEALTH INC ($GHDX).
Latest Insider Trading Transactions of Dean L Schorno
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 2.42 | 50,000 | 121,000 | 50,000 | |
Jan 29 2021 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 3.54 | 112,500 | 398,250 | 112,500 | |
Feb 07 2020 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 2.42 | 200,000 | 484,000 | 200,000 | |
Nov 20 2019 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 3.44 | 83,750 | 288,100 | 83,750 | |
May 23 2019 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Buy | P | 2.13 | 3,274 | 6,971 | 50,000 | 46.7 K to 50 K (+7.01 %) |
May 23 2019 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Buy | P | 2.13 | 46,726 | 99,573 | 46,726 | 0 to 46.7 K |
Mar 22 2019 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 3.44 | 83,750 | 288,100 | 83,750 | |
Jan 25 2019 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 2.00 | 162,500 | 325,000 | 162,500 | |
Jun 06 2018 | RIGL | RIGEL PHARMACEUTIC ... | Schorno Dean L | EVP &Chief Financia ... | Option Exercise | A | 3.44 | 167,500 | 576,200 | 167,500 | |
Jun 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 2,000 | 34,360 | 7,152 | |
Jun 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 18.89 | 2,000 | 37,780 | 14,000 | |
Jun 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 27.62 | 4,000 | 110,487 | 24,524 | 28.5 K to 24.5 K (-14.02 %) |
Jun 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 18.89 | 2,000 | 37,780 | 28,524 | 26.5 K to 28.5 K (+7.54 %) |
Jun 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 2,000 | 34,360 | 26,524 | 24.5 K to 26.5 K (+8.16 %) |
May 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 18.89 | 2,000 | 37,780 | 16,000 | |
May 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 2,000 | 34,360 | 9,152 | |
May 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 25.09 | 4,000 | 100,359 | 23,814 | 27.8 K to 23.8 K (-14.38 %) |
May 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 18.89 | 2,000 | 37,780 | 27,814 | 25.8 K to 27.8 K (+7.75 %) |
May 13 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 2,000 | 34,360 | 25,814 | 23.8 K to 25.8 K (+8.40 %) |
Feb 19 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 27.62 | 442 | 12,208 | 23,814 | 24.3 K to 23.8 K (-1.82 %) |
Feb 19 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 27.62 | 580 | 16,020 | 24,256 | 24.8 K to 24.3 K (-2.34 %) |
Feb 19 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 27.62 | 571 | 15,771 | 24,836 | 25.4 K to 24.8 K (-2.25 %) |
Jan 30 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 30.84 | 25,520 | 787,037 | 25,520 | |
Jan 30 2014 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 3,850 | 0 | 25,407 | 21.6 K to 25.4 K (+17.86 %) |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 2,000 | 34,360 | 11,152 | |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.33 | 1,000 | 17,330 | 1,848 | |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.25 | 2,000 | 66,507 | 21,557 | 23.6 K to 21.6 K (-8.49 %) |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.25 | 1,000 | 33,254 | 23,557 | 24.6 K to 23.6 K (-4.07 %) |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 2,000 | 34,360 | 24,557 | 22.6 K to 24.6 K (+8.87 %) |
Dec 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.33 | 1,000 | 17,330 | 22,557 | 21.6 K to 22.6 K (+4.64 %) |
Nov 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.33 | 3,000 | 51,990 | 2,848 | |
Nov 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.36 | 3,000 | 100,090 | 21,436 | 24.4 K to 21.4 K (-12.28 %) |
Nov 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.33 | 3,000 | 51,990 | 24,436 | 21.4 K to 24.4 K (+14.00 %) |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 950 | 16,321 | 13,152 | |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.33 | 3,050 | 52,857 | 5,848 | |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 32.90 | 3,050 | 100,345 | 21,436 | 24.5 K to 21.4 K (-12.46 %) |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.33 | 3,050 | 52,857 | 24,486 | 21.4 K to 24.5 K (+14.23 %) |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 32.90 | 950 | 31,255 | 21,436 | 22.4 K to 21.4 K (-4.24 %) |
Sep 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 950 | 16,321 | 22,386 | 21.4 K to 22.4 K (+4.43 %) |
Aug 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 4,000 | 68,720 | 17,000 | |
Aug 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.15 | 4,000 | 132,581 | 21,436 | 25.4 K to 21.4 K (-15.73 %) |
Aug 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 4,000 | 68,720 | 25,436 | 21.4 K to 25.4 K (+18.66 %) |
Jul 29 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 3,600 | 0 | 21,436 | 17.8 K to 21.4 K (+20.18 %) |
Jul 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.33 | 4,000 | 69,320 | 6,000 | |
Jul 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.81 | 4,000 | 135,237 | 17,836 | 21.8 K to 17.8 K (-18.32 %) |
Jul 10 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.33 | 4,000 | 69,320 | 21,836 | 17.8 K to 21.8 K (+22.43 %) |
Jun 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.33 | 4,000 | 69,320 | 10,000 | |
Jun 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 35.88 | 4,000 | 143,525 | 17,836 | 21.8 K to 17.8 K (-18.32 %) |
Jun 12 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.33 | 4,000 | 69,320 | 21,836 | 17.8 K to 21.8 K (+22.43 %) |
May 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 17.18 | 4,000 | 68,720 | 21,000 | |
May 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 36.02 | 4,000 | 144,088 | 17,092 | 21.1 K to 17.1 K (-18.96 %) |
May 13 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 17.18 | 4,000 | 68,720 | 21,092 | 17.1 K to 21.1 K (+23.40 %) |
Feb 20 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 28.77 | 585 | 16,830 | 16,214 | 16.8 K to 16.2 K (-3.48 %) |
Feb 20 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 28.77 | 556 | 15,996 | 16,799 | 17.4 K to 16.8 K (-3.20 %) |
Feb 07 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 28.05 | 27,000 | 757,350 | 27,000 | |
Jan 11 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 9.39 | 2,625 | 24,649 | 0 | |
Jan 11 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 2,625 | 73,500 | 17,355 | 20 K to 17.4 K (-13.14 %) |
Jan 11 2013 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 2,625 | 24,649 | 19,980 | 17.4 K to 20 K (+15.13 %) |
Dec 12 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 9.39 | 3,000 | 28,170 | 2,625 | |
Dec 12 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 3,000 | 84,000 | 17,355 | 20.4 K to 17.4 K (-14.74 %) |
Dec 12 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 3,000 | 28,170 | 20,355 | 17.4 K to 20.4 K (+17.29 %) |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 9.39 | 2,800 | 26,292 | 5,625 | |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 9.39 | 200 | 1,878 | 8,425 | |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 2,800 | 78,400 | 17,355 | 20.2 K to 17.4 K (-13.89 %) |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 2,800 | 26,292 | 20,155 | 17.4 K to 20.2 K (+16.13 %) |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 200 | 5,600 | 17,355 | 17.6 K to 17.4 K (-1.14 %) |
Nov 14 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 200 | 1,878 | 17,555 | 17.4 K to 17.6 K (+1.15 %) |
Oct 16 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 9.39 | 3,000 | 28,170 | 8,625 | |
Oct 16 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.79 | 3,000 | 101,358 | 17,355 | 20.4 K to 17.4 K (-14.74 %) |
Oct 16 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 3,000 | 28,170 | 20,355 | 17.4 K to 20.4 K (+17.29 %) |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.69 | 1,000 | 33,686 | 17,355 | 18.4 K to 17.4 K (-5.45 %) |
Apr 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 27.98 | 1,000 | 27,980 | 18,355 | 19.4 K to 18.4 K (-5.17 %) |
Mar 19 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 31.08 | 1,000 | 31,080 | 19,355 | 20.4 K to 19.4 K (-4.91 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 28.97 | 545 | 15,789 | 20,600 | 21.1 K to 20.6 K (-2.58 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.76 | 755 | 21,714 | 21,145 | 21.9 K to 21.1 K (-3.45 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 29.34 | 36,000 | 1,056,240 | 36,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 4,000 | 0 | 21,900 | 17.9 K to 21.9 K (+22.35 %) |
Jan 18 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 1,000 | 27,999 | 17,900 | 18.9 K to 17.9 K (-5.29 %) |
Jun 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 25.91 | 1,000 | 25,909 | 18,900 | 19.9 K to 18.9 K (-5.03 %) |
May 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 26.48 | 1,000 | 26,479 | 19,900 | 20.9 K to 19.9 K (-4.78 %) |
Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 25.32 | 1,000 | 25,319 | 20,900 | 21.9 K to 20.9 K (-4.57 %) |
Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 23.79 | 1,000 | 23,787 | 21,900 | 22.9 K to 21.9 K (-4.37 %) |
Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 22.51 | 1,000 | 22,506 | 22,900 | 23.9 K to 22.9 K (-4.18 %) |
Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 22.98 | 33,000 | 758,340 | 33,000 | |
Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 3,900 | 0 | 23,900 | 20 K to 23.9 K (+19.50 %) |
Jan 19 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | M | 2.88 | 1,276 | 3,675 | 0 | |
Jan 19 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 21.06 | 1,276 | 26,871 | 20,000 | 21.3 K to 20 K (-6.00 %) |
Jan 19 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 2.88 | 1,276 | 3,675 | 21,276 | 20 K to 21.3 K (+6.38 %) |
Page: 1